Living the CRISPR dream

Caribou Biosciences, Inc., one of a handful of biotechs working on therapies based around gene editing, is at a pivotal point as it gears up for clinical trials of its CRISPR-based technology. pharmaphorum’s George Underwood spoke with CEO Rachel Haurwitz at this year’s eyeforpharma conference in Barcelona.